Lorillard
A Safety Assessment of Ingredients Added to Tobacco in the Manufacture of Cigarettes
Fields
- Author
- Doull, J.
- Frawley, J.P.
- George, W.
- Loomis, T.
- Squire, R.A.
- Frawley, J.P.
- Type
- REPT, OTHER REPORT
- BIBL, BIBLIOGRAPHY
- RESU, RESUME
- BIBL, BIBLIOGRAPHY
- Alias
- 91835933/91836014
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Recipient (Organization)
- C+B
- Named Organization
- Buffalo General Hospital
- Center for Environmental + Occupational
- Cornell Univ
- Fair Haven Animal Hospital
- FDA, Food and Drug Administration
- Georgetown Univ
- Health + Environment Intl
- Hercules
- John Hopkins Univ
- Mcgee Hospital
- NCI, Natl Cancer Inst
- Robert A Squire Associates
- School of Public Health + Tropical Medic
- Surgical Research Team of Korea
- Tulane Univ
- Unic of Wa
- Univ of Buffalo
- Univ of Chicago
- Univ of Ks Medical Center
- Univ of Md
- Univ of Mi
- Univ of Mn
- US Air Force Radiation Lab
- US Army
- US Army Medical Corps
- US Marine Hospital
- Yale Univ
- Adria Lab
- Army Medical Service Graduate School
- Center for Environmental + Occupational
- Date Loaded
- 12 Feb 1999
- Document File
- 91835932/91836236/Missing
- Master ID
- 91835933/6014
Related Documents: - Litigation
- Stmn/Produced
- Author (Organization)
- Health + Environment Intl
- Univ of Ks Medical Center
- Characteristic
- MARG, MARGINALIA
- PARE, PARENT
- UCSF Legacy ID
- gpa30e00
Document Images
A SAFETY ASSESSMENT OF
INGREDIENTS ADDED TO TOBACCO IN THE
MANUFACTURE OF CIGARETTES
by
John Doull, Ph.D., M.D.
John P. Frawley, Ph.D.
William George, Ph.D.
Ted Loomis, Ph.D., M.D.
Robert A. Squire, Ph.D., D.V.M.
Submitted to
Covington & Burling
December 1993
.

r'rom the desk of
Stanley Temko - March 11, 1994
Arthur --
Here is an extra copy of the ~
consultation paper, which already incliles
the curriculum vitae. at

~

A SAFETY ASSESSMENT OF
INGREDIENTS ADDED TO TOBACCO IN THE
MANUFACTURE OF CIGARETTES
I. INTRODUCTION
Flavoring ingredients have traditionally been added to
tobacco, and tobacco used in cigarettes commercially manufac-
tured in the United States has always contained such ingredi-
ents. Non-tobacco ingredients consist of 3 general types:
Processing aids are used to adjust products to meet
consumer demands, such as lower yields of "tar" or nicotine, and
to facilitate the manufacturing process. Most processing aids
are recovered during manufacturing, although minute residues of
a few parts per million (ppm) range may remain in the tobacco.
An example of a processing aid commonly used in cigarette manu-
facturing is carbon dioxide.
Casing Materials and Humectants are added to replace
~
sugars lost during curing of the tobacco, to retain moisture, as
a carrier for flavor, and to make the smoke smoother and milder.
All casings and humectants used by United States cigarette manu-
facturers are foods, food products, or ingredients approved for
use in food by the Food and Drug Administration (FDA). An
example of a widely used casing material is sugar, and an
example of a humectant used in cigarette tobaccos is propylene
glycol.
Flavorincs are added to tobacco to impart distinctive
flavors, and to fortify natural flavors lost during curinq and
processing of tobacco. M They consist of natural herbs and

2
spices, or their essential oils, as well as synthetic flavors.
Most flavorings occur at very low levels (i.e. < 1 ppm), usually
as part of specific proprietary formulations. An example of
flavorings commonly added to cigarette tobacco is vanillin.
II. THE EVALUATION OF INGREDIENTS ADDED TO CIGARETTE
TOBACCO
The authors of this report, whose qualifications are
summarized in the appendix, each independently reviewed the
scientific data on ingredients added to cigarette tobacco, and
this report represents their consensus on the safety of the
ingredients.
The material examined was extensive, and included the
confidential list of the ingredients added to tobacco in the
manufacture of cigarettes. The authors were also provided with
summary data of all relevant published and unpublished toxicity
tests and reports, as well as the original publications of data
when requested. Pyrolysis and transfer rate data, maximum use
levels, and annual poundage data for the ingredients were also
evaluated. Each scientist independently visited the individual
tobacco companies to examine the testing and research programs
used for the ingredients. Reports and raw data from the studies
were made available and were examined as necessary, and each
scientist formed an independent opinion regarding the adequacy
of the testing and safety of each ingredient.
0
I

3
I
,
Q
4
III. TOXICITY DATA ON INGREDIENTS ADDED TO CIGARETTE
TOBACCO
Approximately 94% of all ingredients added to
cigarette tobacco in the United States are approved as food
additives by the FDA, or have been given the status "Generally
Recognized As Safe" (GRAS) by the FDA or other expert com-
mittees. Some ingredients are highly volatile and are, thus,
lost during the manufacturing process rather than being present
in the finished cigarette. Moreover, many of the ingredients
are identical or essentially similar in composition to natural
leaf tobacco components. The pyrolysis products of such
ingredients are not expected to depart significantly from the
amounts or types of components generated from a range of
additive-free tobaccos or tobacco blends. Furthermore, the
ingredients 4o not contribute measurably to tar yields.
The 28 non-tobacco ingredients that are present at the
highest levels in cigarettes occur at levels ranging from 0.05%
to 11.58% by weight, the latter being sugars. These ingredi-
ents, along with the processing aids, also account for more than
99% of the total weight of the ingredients added to cigarette
tobacco. All of the remaining non-tobacco ingredients that are
present in cigarettes occur at levels below 500 ppm ( 0. 058 ), and
over one-third occur at levels below 1 ppm (0.0001%).
The authors reviewed extensive data on the, ingredients
added to cigarette tobacco from large numbers of pubiiehed,and
unpublished studies. Included among these data were findings

4
from in vitro and in vivo tests on metabolism, genotoxicity and
reproduction, as well as acute, subchronic, and chronic toxicity
tests. These studies are of the same type as those used to
assess the biological effects of food additives, drugs and
environmental chemicals. The objectives of these studies are to
determine the exposure levels at which adverse effects may occur
and the nature of the adverse effects.
~ Metabolism studies specifically examine the manner in
which a substance is absorbed in the body, broken down, and
~ eliminated.
administered, These processes can all be influenced by the doses
and they also may vary among species. Such
information is, therefore, often essential for determining the
relevance of high dose effects in animals to the relatively low
,
;.~
levels of human exposure.
~
Genotoxicity studies assess the capacity of a chemical
to alter the genetic material in cells. Tests are conducted to
detect the potential for inducing either gene mutations,
chromosome damage, or DNA damage. Substances which experts
recognize as clearly positive in such tests may be harmful,
particularly with regard to potential risks of cancer or birth
defects.
Acute, subchronic and chronic toxicity studies involve
the administration of test substances to animals by routes
similar or analogous to those known for humans, at various
doses, and for time peripds ranging from very brief to lifetime

5
exposures. Animal studies with the ingredients added to
cigarette tobacco have included skin painting, inhalation, and
oral routes of exposure. The objectives of such studies are to
identify the type(s) of toxicity and the organs affected at high
test doses, to determine levels of exposure that will pose no
unacceptable risks to humans and, in the case of skin painting,
to determine tumor promotion effects. These studies require
thorough clinical and pathologic evaluations of many test
animals during and following the exposures, plus a final
interpretation of the relevance of the findings to human risk.
Reproductive studies are specialized types of sub-
chronic and chronic toxicity experiments which specifically
examine the effects of a test substance on fertility, gestation,
and fetal and neonatal development.
In- reviewing the data related to the safety of
ingredients added to cigarette tobacco, emphasis was given to
the major ingredients (those comprising 99% of the ingredients
added), since exposure to these would be expected to be highest.
Most ingredients are present at very low levels as components of
proprietary flavor formulations, and exposure, if any, would be
toxicologically insignificant. Exposure to many of these flavor
ingredients is, in fact, greater through the diet than it is
through cigarette smoking.
Although all types of toxicological data have some
utility for evaluating the safety of ingredients added to
M

6
cigarette tobacco, particularly relevant are inhalation studies
involving actual smoking experiments in animals which compare
the biological effects of inhaling tobacco smoke with and
without added ingredients. In such experiments, animals inhale
smoke from burning cigarettes for extended periods, and toxi-
cological effects are assessed by thorough clinical and patho-
logic examinations. Although all body systems are examined,
emphasis is given to the upper and lower respiratory tracts and
the cardiovascular system. Ingredients added to cigarette
tobacco have not been observed to induce adverse effects in
these experiments. In fact, in many cases added ingredients
have reduced the levels of irritation from tobacco smoke.
The authors also reviewed the available data on
pyrolysis of the ingredients added to cigarette tobacco. Based
~
upon such data from representative ingredients, it has been
determined that most volatile ingredients do not pyrolyze in
burning cigarettes, i.e., they do not decompose or chemically
change as a result of heat. They are transferred intact in
smoke. Thus, if there is exposure and absorption, metabolism
would be similar to ingestion. Among those that do pyrolyze,
their chemical similarities to tobacco leaf components, and
their relatively low levels, suggest that they do not signi-
ficantly alter the composition of tobacco smoke. In any event,
toxicity from pyrolysis products would be evident in smoking

- 7 -
studies and, as indicated above, such studies have been
negative.
Based upon analyses of all of the toxicological data
reviewed by the authors of this report, it was concluded that
there was no evidence that any ingredient added to cigarette
tobacco produces harmful effects under the conditions of use in
cigarettes.
IV. SUMMARY AND CONCLUSION
Ingredients are added to tobacco to aid in processing,
retain moisture, add flavor, and reduce "tar" and nicotine
yield. They have always been used in commercially manufactured
cigarettes in the United States. Most are present at extremely
low levels, and, as most ingredients are essentially similar to
natural tobacco components, the pyrolysis-of these ingredients
is not expected to depart significantly from the pyrolysis of
additive-free tobacco.
It is important to recognize that the use of these
ingredients has enabled manufacturers to develop cigarettes with
lower "tar" and nicotine yields than would otherwise be avail-
able, and the primary issue in safety assessment is whether or
not cigarettes are potentially hazardous as a result of the
added ingredients. A careful analysis of the scientific data
clearly indicates that this is not the case.
